MACROGENICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $19.5M | $-36.8M | $-14.2M | $16.8M | $-36.3M | $-41.0M | $-15.4M | $56.3M |
| Depreciation & Amortization | $708.0K | $1.7M | $1.7M | $1.8M | $1.9M | $1.8M | $2.1M | $1.8M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.0M | $2.6M | $2.7M | $3.5M | $3.7M | $4.4M | $11.3M | $6.0M |
| Net Cash from Operating Activities | $-40.7M | $-35.8M | $43.0M | $-30.2M | $-47.0M | $-46.9M | $-38.4M | $60.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $806.0K | $344.0K | $244.0K | $426.0K | $715.0K | $529.0K | $620.0K | $592.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $28.0M | $45.3M | $-66.0M | $-20.4M | $-37.6M | $9.9M | $41.5M | $35.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $60.2M | $-207.0K | $57.0K | $0 | $69.7M | $-282.0K | $155.0K | $-68.0K |
| Net Change in Cash | $47.4M | $9.3M | $-22.9M | $-50.6M | $-14.9M | $-37.3M | $3.2M | $95.7M |
| Free Cash Flow | $-41.6M | $-36.2M | $42.8M | $-30.6M | $-47.7M | $-47.4M | $-39.0M | $59.6M |